ArticleJournal of hepatocellular carcinoma2026

HAIC Combined with Lenvatinib and Pembrolizumab for Unresectable Hepatocellular Carcinoma: A Retrospective Study.

Jun Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.